These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
470 related items for PubMed ID: 19402154
1. Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis. Lin YS, Lin LC, Lin SW. Laryngoscope; 2009 Jul; 119(7):1348-52. PubMed ID: 19402154 [Abstract] [Full Text] [Related]
2. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS. Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654 [Abstract] [Full Text] [Related]
3. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Hareyama M, Sakata K, Shirato H, Nishioka T, Nishio M, Suzuki K, Saitoh A, Oouchi A, Fukuda S, Himi T. Cancer; 2002 Apr 15; 94(8):2217-23. PubMed ID: 12001120 [Abstract] [Full Text] [Related]
4. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. Lee AW, Tung SY, Chua DT, Ngan RK, Chappell R, Tung R, Siu L, Ng WT, Sze WK, Au GK, Law SC, O'Sullivan B, Yau TK, Leung TW, Au JS, Sze WM, Choi CW, Fung KK, Lau JT, Lau WH. J Natl Cancer Inst; 2010 Aug 04; 102(15):1188-98. PubMed ID: 20634482 [Abstract] [Full Text] [Related]
5. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival. Ozyar E, Gurkaynak M, Yildiz F, Atahan IL. Radiother Oncol; 2004 Jul 04; 72(1):71-7. PubMed ID: 15236877 [Abstract] [Full Text] [Related]
6. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma. Song CH, Wu HG, Heo DS, Kim KH, Sung MW, Park CI. Laryngoscope; 2008 Apr 04; 118(4):663-70. PubMed ID: 18216741 [Abstract] [Full Text] [Related]
7. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Kwong DL, Sham JS, Leung LH, Cheng AC, Ng WM, Kwong PW, Lui WM, Yau CC, Wu PM, Wei W, Au G. Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):374-81. PubMed ID: 16213105 [Abstract] [Full Text] [Related]
8. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma. Lin JC, Jan JS, Chen KY, Hsu CY, Liang WM, Wang WY. Head Neck; 2003 Jun 01; 25(6):438-50. PubMed ID: 12784235 [Abstract] [Full Text] [Related]
9. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma. Chua DT, Sham JS, Au GK. Head Neck; 2004 Feb 01; 26(2):118-26. PubMed ID: 14762880 [Abstract] [Full Text] [Related]
10. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials. Chua DT, Ma J, Sham JS, Mai HQ, Choy DT, Hong MH, Lu TX, Au GK, Min HQ. Int J Radiat Oncol Biol Phys; 2006 Aug 01; 65(5):1300-6. PubMed ID: 16750333 [Abstract] [Full Text] [Related]
11. Concomitant chemotherapy and radiotherapy for locally advanced nasopharyngeal carcinoma. Cheng SH, Liu TW, Jian JJ, Tsai SY, Hao SP, Huang CH, Liu MC, Yu B, Huang AT. Cancer J Sci Am; 1997 Aug 01; 3(2):100-6. PubMed ID: 9099460 [Abstract] [Full Text] [Related]
12. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Chua DT, Nicholls JM, Sham JS, Au GK. Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):11-20. PubMed ID: 15093894 [Abstract] [Full Text] [Related]
13. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. Chua DT, Ma J, Sham JS, Mai HQ, Choy DT, Hong MH, Lu TX, Min HQ. J Clin Oncol; 2005 Feb 20; 23(6):1118-24. PubMed ID: 15657403 [Abstract] [Full Text] [Related]
14. Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft für Pädiatrische Onkologie und Hämatologie. Mertens R, Granzen B, Lassay L, Gademann G, Hess CF, Heimann G. Cancer; 1997 Sep 01; 80(5):951-9. PubMed ID: 9307197 [Abstract] [Full Text] [Related]
15. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china. Chen Y, Liu MZ, Liang SB, Zong JF, Mao YP, Tang LL, Guo Y, Lin AH, Zeng XF, Ma J. Int J Radiat Oncol Biol Phys; 2008 Aug 01; 71(5):1356-64. PubMed ID: 18472356 [Abstract] [Full Text] [Related]
16. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma. Benasso M, Sanguineti G, D'Amico M, Corvò R, Ricci I, Numico G, Guarneri D, Vitale V, Pallestrini E, Santelli A, Rosso R. Br J Cancer; 2000 Dec 01; 83(11):1437-42. PubMed ID: 11076650 [Abstract] [Full Text] [Related]
17. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. Lee AW, Lau WH, Tung SY, Chua DT, Chappell R, Xu L, Siu L, Sze WM, Leung TW, Sham JS, Ngan RK, Law SC, Yau TK, Au JS, O'Sullivan B, Pang ES, O SK, Au GK, Lau JT, Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol; 2005 Oct 01; 23(28):6966-75. PubMed ID: 16192584 [Abstract] [Full Text] [Related]